Achievements
- Y Combinator S21 alum, co-founded Catena Biosciences backed by Y Combinator and raised over $8M from Amgen Ventures and Y Combinator investors
- Led Rad AI to over $10M ARR and secured Series B funding
- Held product management and marketing roles at Facebook, Google, and Microsoft in AI healthcare, cloud, biotech
- Expertise in AI model integration, responsible AI, and regulatory compliance in clinical healthcare
- Founded a biotech startup focused on protein conjugation for autoimmune diseases, cancer, and vaccines
- Recognized for combining tech, biotech, and healthcare to push innovative solutions
Meet Geo Guillen
Let’s dive into the world of Geo Guillen, the guy’s a beast in the startup world, and his story is straight-up inspiring. So, he’s a YC S21 alum, which already puts him in that rarefied circle of founders who really jumped into the deep end. But what’s crazy is his background before jumping into the startup hustle. The dude’s worked at all the big guns, Facebook, Google, Microsoft, like, the holy trinity of tech giants. He’s been in product management and marketing roles at all three, which means he’s seen the tech world from every angle: AI healthcare, cloud stuff, biotech, you name it. That’s a pretty wild mix, honestly. It shows he’s not just a one-trick pony; he’s got a broad skill set and a deep understanding of how tech and biotech can collide.
Now, here’s where it gets really cool. After all that big corporate experience, he jumped into the biotech startup scene with Catena Biosciences, a company he co-founded and now crushes as COO. This isn’t just some side project, they’re backed by Y Combinator, which means they’re the real deal, and they’re working on protein conjugation platforms for autoimmune diseases, cancer, and vaccines. Basically, Geo’s now at the forefront of biotech innovation, trying to solve some of the toughest health problems out there. And he’s not just messing around; he’s helped raise over $8 million from big names like Amgen Ventures and YC investors. That’s no joke.
What does this all say about him? Well, it’s clear Geo’s super motivated to make an impact. He’s been around the block, seen how big tech works, and then pivoted into biotech because he probably saw the possible for tech to change healthcare in a massive way. His process screams that he’s all about pushing boundaries, whether it’s scaling a product to over $10M ARR at Rad AI or leading modern biotech research. He’s got that rare combo of business smarts, technical depth, and a real passion for making a difference in medicine.
Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.
Talk to herAnd if you look at his background, business degree from Washington State U, an MBA from UC Berkeley Haas, it’s like he’s got the perfect toolkit to blend tech, business, and healthcare. Plus, he’s recognized for his expertise in AI models in clinical healthcare and responsible AI strategies, which is huge because that’s the future.
Bottom line? Geo Guillen is one of those founders who’s not just in it to build a company, he’s in it to change lives. He’s a perfect example of someone who took all his experience from tech giants, combined it with a crazy drive, and jumped into biotech to really make an impact. No cap, this guy’s just getting started, and I’m telling you, he’s one to watch.

Select your comment type:
If something is wrong about Geo Guillen, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)